Syncona is a healthcare company focused on founding, building, and funding life science businesses to deliver transformational treatments in areas of high unmet need. With a diversified portfolio of clinical and pre-clinical companies, Syncona leverages exceptional science and a long-term view to improve patient lives, create sustainable companies, and provide strong returns to shareholders. The company is publicly traded on the London Stock Exchange (LON: SYNC).
Recent Transactions involving Syncona
Deal | Target | Platform | Buyer | Industry |
---|---|---|---|---|
Syncona to Acquire Applied Genetic Technologies Corporation |
Applied Genetic Technologies Corporation |
Syncona |
Gene Therapy |
The Lower and Middle Market M&A Platform
See how PrivSource can help you close more deals.
Learn more →